Navigation Links
BIO CEO & Investor 2008 Conference to Webcast Millennium Presentation
Date:2/4/2008

CAMBRIDGE, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the BIO CEO & Investor 2008 Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

The presentation will include an overview of the Company, VELCADE(R) (bortezomib) for Injection, other product candidates and upcoming corporate events. The presentation will be delivered at 11:45 a.m. ET on Monday, February 11, 2007 from the Waldorf Astoria Hotel in New York, NY. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.

Contact:

Kyle Kuvalanka

(617) 761-4734


'/>"/>
SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
3. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
4. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
5. Stryker to Present at Investor Conference
6. AMERIGROUP Corporation to Host Investor Day
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
9. Par Pharmaceutical Provides Summary of Analyst/Investor Day
10. Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations
11. SGX Pharmaceuticals to Present at the BIO InvestorForum 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... "ProDOF is the perfect set of tools for video ... subject in a scene," said Christina Austin - CEO of Pixel Film Studios. , ... Easily create the illusion of a DSLR racking focus from one area into the next. ...
(Date:1/21/2017)... ... ... Phytocéane invites you to take an exotic journey deep into ... ZANZIBAR SHOWER GEL. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the ... coral to create this gentle, crystal-clear shower gel to cleanse the body and promote ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dermatology has recently joined their multi-specialty medical group. The dermatology practice provides ... services. , “We’re excited to add this excellent dermatology practice to our group’s ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, 20 million women and ... recovery, they often feel shame for having struggled with an eating disorder as well ... workshop, “Rising Strong in Life After an Eating Disorder” -- to be featured at ...
(Date:1/20/2017)... ... , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, ... on wheels, it can be wheeled out of the way and stored when not in ... "We have transformed the feedback from customers into specific enhancements and created a new product ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... DIEGO , Jan. 23, 2017  Using ... patients at high risk for acute kidney injury ... recommended by globally-recognized care guidelines significantly ... to severe AKI more than 33 percent, according ... in the journal Intensive Care Medicine. ...
(Date:1/23/2017)... Ahead of today,s trading session, Stock-Callers.com draws ... fared at the close: Kite Pharma Inc. (NASDAQ: KITE ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ). According ... on Friday, January 20 th , 2017, down on the day ... these stocks now at: ...
(Date:1/23/2017)... York , January 23, 2017 A ... Prenatal Testing Market was valued at US$0.53 bn in 2013 ... at a strong 17.50% CAGR between 2014 and 2022. The title ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - ... Non-invasive prenatal ...
Breaking Medicine Technology: